Drug discovery traditionally takes over a decade and billions of dollars — AI is compressing that timeline dramatically. AlphaFold's protein structure predictions have accelerated target identification across the pharmaceutical industry. Insilico Medicine and Exscientia use generative chemistry to design novel drug candidates, while Atomwise applies deep learning to molecular docking and Recursion runs biology experiments at robotic scale.
1
4.9
New
2
4.8
New
3
4.8
New
4
4.8
New
5
4.7
New
6
4.7
New
7
4.6
New